Alan M. Garber - 01 May 2025 Form 4 Insider Report for VERTEX PHARMACEUTICALS INC / MA (VRTX)

Role: Director
Signature: /s/ Christiana Stevenson, Attorney-in-Fact
Issuer symbol: VRTX
Transactions as of: 01 May 2025
Net transactions value: $0
Form type: 4
Filing time: 05 May 2025, 16:19:11 UTC
Previous filing: 03 May 2024
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Garber Alan M	Director	C/O VERTEX PHARMACEUTICALS INCORPORATED, 50 NORTHERN AVENUE, BOSTON	/s/ Christiana Stevenson, Attorney-in-Fact	05 May 2025	0001312907

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	VRTX	Common Stock	Award	$0	+398	+6.1%	$0.000000	6,872	01 May 2025	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	VRTX	Stock Option (Right to Buy)	Award	$0	+1,199		$0.000000	1,199	01 May 2025	Common Stock	1,199	$502.97	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Restricted stock unit award that vests, subject to certain limited exceptions, on the first anniversary of the grant date.
F2	Fully vested.